• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Greenbrook TMS Announces Closing of Acquisition of Achieve TMS

Share:

September 30, 2019

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce the closing of the quisition of Achieve TMS Centers, LLC and Achieve TMS Alaska, LLC (collectively, “Achieve TMS”), as previously announced
on September 11, 2019 (the “Acquisition”).

The initial purchase price for Achieve TMS was US$10.5 million, net of Achieve TMS’ cash and debt and subject to customary working capital adjustments.Approximately US$2.6 million was satisfied by the issuance of 1,431,736 common shares of Greenbrook. A portion of the purchase price payable in respect of the Acquisition is subject to an earn-out based on the EBITDA achieved by Achieve TMS during the twelve-month period following the closing of the
Acquisition.

Bill Leonard, President and CEO commented: “The closing of this acquisition will provide Greenbrook with a national footprint of over 100 TMS Centers, solidifying our position as a leading provider of Transcranial Magnetic
Stimulation (TMS) therapy in the United States. We look forward to continuing to increase awareness of, and accessibility to, TMS in collaboration with our new colleagues at Achieve TMS.”

Date: September 30, 2019

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Bloomberg

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Workflow Management System Solv Adds New EHR Integrations, In-App Lab ResultsWorkflow Management System Solv Adds New EHR Integrations, In-App Lab Results
  • AGC Enters Agreement to Acquire Synthetic Pharmaceutical Active Ingredient-manufacturing Plant in SpainAGC Enters Agreement to Acquire Synthetic Pharmaceutical Active Ingredient-manufacturing Plant in Spain
  • Could blockchain ensure integrity of clinical trial data?Could blockchain ensure integrity of clinical trial data?
  • Can Digital Health Solutions Remove Stigmas Around Addiction?Can Digital Health Solutions Remove Stigmas Around Addiction?
  • A Clearer Vision for Gene Therapies: Gyroscope and Orbit Biomedical MergeA Clearer Vision for Gene Therapies: Gyroscope and Orbit Biomedical Merge
  • SHINE Closes $80-million Series C Financing Supported by Fidelity Management and Research Company LLCSHINE Closes $80-million Series C Financing Supported by Fidelity Management and Research Company LLC
  • GuideWell Connect Acquires Onlife HealthGuideWell Connect Acquires Onlife Health
  • Revelation Pharma Completes Two AcquisitionsRevelation Pharma Completes Two Acquisitions

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications